May 01, 2024 / 11:00AM GMT
Nick Stone -
Hello, everyone. Welcome to today's call and webcast. The presentation was sent to our distribution list by e-mail, and you can find this on gsk.com.
Please turn to Slide 2. This is the usual safe harbor statement. We'll comment on our performance using constant exchange rates, or CR unless stated otherwise. As a reminder, adjusted results are now referred to as core like many European pharmaceutical peers.
Please turn to Slide 3. Today's call will last approximately 1 hour with the presentation taking around 25 minutes and the remaining time for your questions. Today, our speakers are Emma Walmsley, Luke Miels, Deborah Waterhouse, and Julie Brown with Tony Wood and David Redfern joining for Q&A. Please ask 1 to 2 questions so that everyone has the chance to participate.
Turning to Slide 4. I will now hand the call over to Emma.
Emma Natasha Walmsley - GSK plc - CEO & Director
Thanks, Nick, and welcome to everybody joining us today. I'm delighted to be presenting to you all with another set of excellent quarterly results
Q1 2024 GSK plc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot